In the second installment of this two-part series, Dr. Stacey Clardy and Dr. Janis Miyasaki discuss how she got involved with the AAN. Show reference: https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Per Borghammer examine the dichotomy that existed before his team began this project. Show reference: https://www.nature.com/articles/s41593-025-01910-9
In the first installment of this two-part series, Dr. Stacey Clardy engages in a thought-provoking conversation with Dr. Janis Miyasaki, asking her to share two invaluable pieces of wisdom. Show reference: https://www.aan.com/news/aan-honors-leader-volunteer-2025-presidents-award
Dr. Jeff Lambe talks about progressive multiple sclerosis. Show references: https://journals.lww.com/co-neurology/abstract/2025/06000/re_defining_progression_in_multiple_sclerosis.4.aspx https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00281-8/abstract https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(14)70256-X/abstract https://www.tandfonline.com/doi/full/10.1080/14737175.2022.2143265 https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0288967 http...
Dr. Justin Abbatemarco discuss autoimmune encephalitis with a focus on outcomes. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
Dr. Jessica Ailani and Dr. Kathleen Digre discuss the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.
In part one of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss current biomarkers for Alzheimer disease and how do you use them in clinic.
Dr. Justin Abbatemarco discusses updates around MOGAD treatments. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2822964 https://jnnp.bmj.com/content/95/11/1054
Dr. Justin Abbatemarco discusses autoimmune encephalitis with a focus on outcomes. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000210109 https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(23)00463-5/abstract
Dr. Halley Alexander discusses the Neurology Today article, “The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting,” by Gina Shaw, available in the latest issue of Neurology Today or at neurologytoday.com . Show reference: The AAN Updates Its Position Statement on Seizures, Driver Licensure, and Medical Reporting...
Dr. Greg Cooper and Dr. Joseph Therriault discuss the use of plasma biomarkers in diagnosing Alzheimer disease. Show reference: https://doi.org/10.1038/s43587-024-00731-y
Dr. Halley Alexander and Dr. Paula Marques discuss sex differences in genetically determined epilepsies. Show reference: https://www.neurology.org/doi/10.1212/NXG.0000000000200233
Dr. Justin Abbatemarco discusses updates around treatments in AQP4+ NMOSD. Show references: https://pubmed.ncbi.nlm.nih.gov/38760098/ https://www.neurology.org/doi/10.1212/NXI.0000000000200071
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how to address questions related to BTK Inhibitors with patients. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss the clinical trial data available in both the relapsing and progressive cohorts. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2415985 https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
Dr. Justin Abbatemarco provides an update on autologous hematopoietic stem cell transplantation in multiple sclerosis. Show reference: https://www.nature.com/articles/s41582-024-01050-x
In this women's history minute, Dr. Alison Christy discusses the life and legacy of Mary A. B. Brazier.
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss the diverse strategies that residency programs implement to ensure residents can continue their education in a protected and supportive environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss how neurology residency programs are incorporating didactic teaching methods to enhance learning outside the clinical environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205
Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200359
Dr. Tesha Monteith discusses an abstract that was presented at the AAN Annual Meeting titled, “Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study.” Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002306.html
In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208987
Prof. Jon Stone, Dr. Laura Strom, and Meagan Watson discuss functional seizures and healthcare costs related to the functional seizure program at the University of Colorado. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200393
Neurology ® Open Access has officially launched! In part two of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the advantages of an open-access publication model. Read the related editorial in Neurology ® Open Access .
Neurology ® Open Access has officially launched! In part one of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the scope and focus of Neurology ® Open Access (NOA). Read the related editorial in Neurology ® Open Access .
In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html
In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html
In part two of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the essence of humanistic care.
